Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Ministers to end Palantir’s contract with NHS in England in 2029

DHSC to extend US tech firm’s contract for two more years to allow time to line up British companies to replace it Ministers will end the NHS’s contract with the controversial tech firm Palantir – but not until 2029, to allow time to line up British companies to replace it. The Department of Health and Social Care (DHSC) has decided to extend Palantir’s contract to provide the federated data…

Ministers to end Palantir’s contract with NHS in England in 2029

In London, the UK government announced plans to end Palantir's contract with the National Health Service (NHS) in 2029. However, the government will not immediately terminate the contract, as some MPs and campaigners had requested. Instead, formal bidding for a "new" contract will commence in the second half of 2027, with the process expected to take 18 months, according to health minister James Frith.

Frith described the extension of Palantir's contract until 2029 as "a bridge, not the destination." The government aims to restore "public trust" and create opportunities for "U.K. sovereign capabilities" through the new procurement round, which will prioritize interoperability, resilience, and trusted common standards. Frith emphasized that non-U.K. firms will also be encouraged to bid for the new contract.

The extension of Palantir's contract has faced significant scrutiny from campaigners, health professionals, and MPs due to controversial views expressed by the company's founders and concerns about vendor lock-in. Two parliamentary committees have called for the NHS contract to be terminated in the past year. The government seeks to provide the health and care system with more choice, greater resilience, and less dependence on any single supplier, as well as better value for taxpayers over time.

Frith noted that the approach will stimulate a more diverse and innovative supplier market, including the use of sovereign AI and internationally developed capabilities. He stressed the importance of avoiding over-dependence and not becoming locked into any single technology. It remains unclear if Palantir will be eligible to compete for the new contract in 2029.

Palantir's spokesperson stated that the announcement is "good news for patients and for the NHS" and expressed pride in the company's work, stating that it is "proud" and will "redouble" its efforts to continue supporting the NHS and "deepen" its investment in the U.K.

Written by urgent.news from Politico EU's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at theguardian.com →

More in Health & Medicine

More from Monday 16 November →